Drug Profile
Oxycodegol - Nektar Therapeutics
Alternative Names: Loxicodegol; NKTR-181; NKTR-181-phosphate; Oxycodegol phosphate; Oxycodegol phosphate - Nektar TherapeuticsLatest Information Update: 03 Mar 2020
Price :
$50
*
At a glance
- Originator Nektar Therapeutics
- Class Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Back pain; Musculoskeletal pain; Pain
Most Recent Events
- 15 Jan 2020 Discontinued - Phase-II for Musculoskeletal pain in USA (PO) (9284019 and Nektar Therapeutics pipeline March 2020)
- 15 Jan 2020 Discontinued - Phase-III for Pain in USA (PO) (9284019 and Nektar Therapeutics pipeline March 2020)
- 15 Jan 2020 Discontinued - Preregistration for Back pain in USA (PO) (9284019 and Nektar Therapeutics pipeline March 2020)